These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3116846)

  • 1. Alterations in hemostatic parameters during hemodialysis with dialyzers of different membrane composition and flow design. Platelet activation and factor VIII-related von Willebrand factor during hemodialysis.
    Schmitt GW; Moake JL; Rudy CK; Vicks SL; Hamburger RJ
    Am J Med; 1987 Sep; 83(3):411-8. PubMed ID: 3116846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of platelets and hemostasis during hemodialysis with six different membranes.
    Verbeelen D; Jochmans K; Herman AG; Van der Niepen P; Sennesael J; De Waele M
    Nephron; 1991; 59(4):567-72. PubMed ID: 1766495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodialysis-associated platelet loss: study of the relative contribution of dialyzer membrane composition and geometry.
    Docci D; Turci F; Del Vecchio C; Bilancioni R; Cenciotti L; Pretolani E
    Int J Artif Organs; 1984 Nov; 7(6):337-40. PubMed ID: 6526528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of platelet von Willebrand factor in the binding of factor VIII to activated platelets.
    Suzuki H; Shima M; Kamisue S; Nakai H; Nogami K; Shibata M; Morichika S; Tanaka I; Giddings JC; Yoshioka A
    Thromb Res; 1998 Jun; 90(5):207-14. PubMed ID: 9694242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of dialyzer geometry on blood coagulation and biocompatibility.
    Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
    Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dialyzer geometry during hemodialysis with cuprophane membranes.
    Taylor JE; McLaren M; Mactier RA; Henderson IS; Stewart WK; Belch JJ
    Kidney Int; 1992 Aug; 42(2):442-7. PubMed ID: 1405328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodialysis-associated platelet activation and thrombocytopenia.
    Hakim RM; Schafer AI
    Am J Med; 1985 Apr; 78(4):575-80. PubMed ID: 3885730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VIII-mediated global hemostasis in the absence of von Willebrand factor.
    Takeyama M; Kasuda S; Sakurai Y; Shima M; Takeda T; Omura S; Naka H; Yoshioka A
    Int J Hematol; 2007 Jun; 85(5):397-402. PubMed ID: 17562614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet and endothelial function tests during metformin treatment in diabetes mellitus (short communication).
    Janka HU
    Horm Metab Res Suppl; 1985; 15():120-2. PubMed ID: 2934311
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of arginine vasopressin (AVP) infusions on circulating concentrations of platelet AVP, factor VIII: C and von Willebrand factor.
    Nussey SS; Bevan DH; Ang VT; Jenkins JS
    Thromb Haemost; 1986 Feb; 55(1):34-6. PubMed ID: 3085262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
    de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
    Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of granulocyte elastase during hemodialysis: effects of different dialyzer membranes.
    Hörl WH; Steinhauer HB; Schollmeyer P
    Kidney Int; 1985 Nov; 28(5):791-6. PubMed ID: 3878906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialyzer membranes: effect of surface area and chemical modification of cellulose on complement and platelet activation.
    Mahiout A; Meinhold H; Kessel M; Schulze H; Baurmeister U
    Artif Organs; 1987 Apr; 11(2):149-54. PubMed ID: 3036050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostatic disturbances induced by two hollow-fiber hemodialysis membranes.
    Reber G; Stoermann C; de Moerloose P; Ruedin P; Leski M
    Int J Artif Organs; 1992 May; 15(5):269-76. PubMed ID: 1601510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Willebrand factor and platelet function.
    Moroose R; Hoyer LW
    Annu Rev Med; 1986; 37():157-63. PubMed ID: 2939788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Willebrand's disease.
    Hoyer LW
    Prog Hemost Thromb; 1976; 3():231-87. PubMed ID: 781732
    [No Abstract]   [Full Text] [Related]  

  • 18. The platelet-endothelial cell--VIII axis.
    Nachman RL; Jaffe EA
    Thromb Haemost; 1976 Feb; 35(1):120-3. PubMed ID: 1085499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of main granulocyte components in patients dialyzed with polycarbonate and cuprophan membranes.
    Hörl WH; Riegel W; Schollmeyer P
    Nephron; 1987; 45(4):272-6. PubMed ID: 3035392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dialyzer geometry on granulocyte and complement activation.
    Schaefer RM; Heidland A; Hörl WH
    Am J Nephrol; 1987; 7(2):121-6. PubMed ID: 3496792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.